Skip to main content
. 2022 Jul;63(7):1064–1069. doi: 10.2967/jnumed.121.263033

TABLE 1.

Baseline Characteristics of Study Participants

Variable Entire population (n = 58) Negative 11C-PiB PET/CT (n = 23) Positive 11C-PiB PET/CT (n = 35) P
Demographics
 Age (y) 64.0 ± 9.1 61.7 ± 7.6 65.5 ± 9.8 0.121
 Male 25 (43.1%) 9 (39.1%) 16 (45.7%) 0.787
 Systolic blood pressure (mm Hg) 109.5 (100.2–119.5) 111.0 (104.5–122.5) 104.0 (92.5–114.0) 0.034
 Diastolic blood pressure (mm Hg) 68.0 ± 7.5 68.5 ± 7.7 67.6 ± 7.5 0.663
 Body mass index (kg/m2) 22.6 ± 3.1 23.1 ± 3.4 22.2 ± 3.9 0.270
Comorbidities
 Hypertension 13 (22.4%) 5 (21.7%) 8 (22.9%) 0.999
 Diabetes 13 (22.4%) 2 (8.7%) 11 (31.4%) 0.087
 Dyslipidemia 6 (10.3%) 1 (4.3%) 5 (14.3%) 0.386
 End-stage renal disease 4 (6.8%) 2 (8.7%) 2 (5.7%) 0.999
 Atrial fibrillation 5 (8.6%) 4 (17.4%) 1 (3.0%) 0.075
 Chemotherapy 51 (87.9%) 22 (95.7%) 29 (82.9%) 0.224
 Autologous PBSCT 10 (17.2%) 7 (30.4%) 3 (8.6%) 0.040
Echocardiography data
 LV end-diastolic dimension (mm) 43.8 ± 5.2 45.1 ± 6.0 43.0 ± 4.4 0.134
 LV end-systolic dimension (mm) 28.8 ± 5.2 29.2 ± 6.0 28.5 ± 4.7 0.640
 LV mass index (kg/m2) 121.2 ± 34.7 116.8 ± 36.8 124.2 ± 33.5 0.430
 LV ejection fraction (%) 56.5 (52.0–62.0) 58.0 (51.5–66.5) 56.0 (52.5–60.5) 0.321
 LV ejection fraction < 60% 19 (32.8%) 10 (43.5%) 9 (25.7%) 0.261
 E velocity (m/s) 0.85 ± 0.28 0.76 ± 0.23 0.91 ± 0.31 0.021
 e’ velocity (cm/s) 4.1 ± 1.1 4.4 ± 1.0 3.8 ± 1.1 0.043
 E/e’ ratio 19.9 (14.9–29.5) 16.7 (13.4–21.0) 22.5 (17.0–33.3) 0.004
 Estimated PASP (mm Hg) 38.0 (32.5–45.0) 37.0 (31.5–42.5) 40.5 (32.8–45.0) 0.441
 Left atrial size (mm) 43.3 ± 6.7 43.1 ± 7.2 43.4 ± 6.4 0.863

PBSCT = peripheral blood stem cell transplantation; LV = left ventricular; PASP = pulmonary arterial systolic pressure.

Data for continuous variables are mean ± SD or median followed by IQ. Data for categoric variables are frequencies followed by percentages. P values are for comparisons between positive and negative 11C-PiB PET/CT groups.